HCA

SEC source: 0000950170-24-088748 · ownership.xml · nonDerivative · entry 2

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,305

SEC source: 0000950170-24-088748 · ownership.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-088693 · ownership.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,510

SEC source: 0000950170-24-087383 · ownership.xml · derivative · entry 4

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,300 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

SEC source: 0000950170-24-087383 · ownership.xml · nonDerivative · entry 2

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,449

SEC source: 0000950170-24-087383 · ownership.xml · nonDerivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-087361 · ownership.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,755

SEC source: 0001209191-24-005677 · doc4.xml · derivative · entry 6

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,045

Underlying: Common Stock · 1,685 shares

Expires 2028-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on October 31, 2019.

SEC source: 0001209191-24-005677 · doc4.xml · derivative · entry 5

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,040 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

SEC source: 0001209191-24-005677 · doc4.xml · nonDerivative · entry 4

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,318

SEC source: 0001209191-24-005677 · doc4.xml · nonDerivative · entry 3

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-24-005677 · doc4.xml · nonDerivative · entry 2

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-24-005677 · doc4.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,454

SEC source: 0001209191-24-005663 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,612

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.31 to $327.00, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-24-005661 · doc4.xml · derivative · entry 9

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,510 shares

Expires 2027-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

SEC source: 0001209191-24-005661 · doc4.xml · derivative · entry 8

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,955 shares

Expires 2026-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.

SEC source: 0001209191-24-005661 · doc4.xml · nonDerivative · entry 3

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,037

SEC source: 0001209191-24-005661 · doc4.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,295

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-24-005661 · doc4.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,785

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-24-005662 · doc4.xml · derivative · entry 6

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.

SEC source: 0001209191-24-005662 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,367

SEC source: 0001209191-24-005662 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By LCF Trust (Reporting Person, Trustee)

Disclosed balance after: 54,308

SEC source: 0000950170-24-128118 · ownership.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 0

SEC source: 0001209191-24-005627 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,623.9692

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.7603 to $317.07, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-24-005626 · doc4.xml · nonDerivative · entry 1

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,185

SEC source: 0001209191-24-005625 · doc4.xml · nonDerivative · entry 2

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 60,497

SEC source: 0001209191-24-005625 · doc4.xml · nonDerivative · entry 1

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001209191-24-005570 · doc4.xml · nonDerivative · entry 4

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,934.9692

F1 · balance_after: Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-24-005570 · doc4.xml · derivative · entry 5

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,660 shares

Expires 2029-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.

SEC source: 0001209191-24-005570 · doc4.xml · nonDerivative · entry 3

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,434.9692

F1 · balance_after: Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-24-005570 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,783.9692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-24-005570 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,123.9692

F1 · balance_after: Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-24-005549 · doc4.xml · nonDerivative · entry 2

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,475

SEC source: 0001209191-24-005549 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,365

SEC source: 0001209191-24-005443 · doc4.xml · nonDerivative · entry 1

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,237

SEC source: 0001209191-24-005455 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,497

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award and 674 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-24-005454 · doc4.xml · nonDerivative · entry 1

Frist William R · CIK 0001433377 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,905

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award and 353 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-24-005451 · doc4.xml · nonDerivative · entry 1

Smith Andrea B · CIK 0001649634 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,512

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-24-005450 · doc4.xml · nonDerivative · entry 1

Riley Wayne Joseph · CIK 0001432895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,875

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-24-005449 · doc4.xml · nonDerivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,478

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award and 481 restricted share units received in lieu of annual cash retainers for service as a director and as independent presiding director. The restricted share units shall vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-24-005448 · doc4.xml · nonDerivative · entry 1

Johnston Hugh F · CIK 0001377489 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,640

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-24-005447 · doc4.xml · nonDerivative · entry 1

DEPARLE NANCY ANN · CIK 0001144511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,756

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-24-005446 · doc4.xml · nonDerivative · entry 1

Dennis Robert J · CIK 0001295441 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,575

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award and 353 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-24-005445 · doc4.xml · nonDerivative · entry 1

CROFTON MEG · CIK 0001665104 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,331

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-24-005444 · doc4.xml · derivative · entry 1

McAlevey Michael R · CIK 0001907875 · EVP - Chief Legal & Admin Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,274

Underlying: Common Stock · 2,274 shares

Expires 2034-04-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on April 29, 2025.

SEC source: 0001209191-24-005443 · doc4.xml · derivative · entry 4

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,096

Underlying: Common Stock · 9,096 shares

Expires 2034-04-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on April 29, 2025.

SEC source: 0001209191-24-004999 · doc4.xml · nonDerivative · entry 4

Wasserman Chad J · CIK 0002010252 · SVP and CIO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,576.3102

F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.

SEC source: 0001209191-24-004999 · doc4.xml · derivative · entry 5

Wasserman Chad J · CIK 0002010252 · SVP and CIO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,190

Underlying: Common Stock · 2,100 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

SEC source: 0001209191-24-004999 · doc4.xml · nonDerivative · entry 3

Wasserman Chad J · CIK 0002010252 · SVP and CIO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,452.3102

F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.